Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* upper limb surgery~* ganglion removal~* k wiring~* Carapal tunnel~Exclusion Criteria:~* Coagulopathy.~* infection at site of injection.~* patient refusal.~* hypersensitivity.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Articaine group (Type: EXPERIMENTAL): Patients in this group are assigned to recieve 30 ml of Articaine 2%
- Bupivacaine (Type: EXPERIMENTAL): Patients in this group are assigned to recieve 30 ml of bupivacaine 0.5%

Based on this trial design, predict the completion outcome and termination type (if applicable).